|
 |
|
 |
|
Acomplia Rimonabant Diet Pills |
Acomplia with Rimonabant as its active component is one of the most sought after medications by the obese and over weight individuals. It is a product of the 2 years of clinical trials undertaken by the French pharma, Sanofi-Aventis. Clinical trials also prove its efficacy for smoking cessation. Although clinical trials do prove usage of Acomplia (Rimonabant) beneficial for smoking cessation but it has not yet been approved for the same.
Use of this weight loss medication is not intended for women planning pregnancy, expectant women, nursing mothers, individuals below the age group of 18 years, diabetics, and heart patients. Discuss with your doctor about the suitability of the Acomplia Rimonabant for usage.
Film-coated Acomplia Rimonabant tablet is available in two strengths of 10mg and 20mg.these tablets are saleable in blister packaging, which can procured solely by means of means of a prescription. Each dose of this medication is supposed to taken in strict adherence to a doctor's advice. Usage of Acomplia (Rimonabant) is usually suggested along with a balanced diet plan and regular workout regime to fetch effective results.
Sale of Acomplia Rimonabant as an effective short-term obesity management has already been approved in several European and Latin-American countries. It was first launched in the UK last year, and since then there has been no looking back. It still awaits its FDA approval for its launch in the US. FDA's decision on Acomplia Rimonabant usage is expected to be released by the month of July.
|
|
|
 |
|
 |
|
|
|
|
